Publication | Closed Access

Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML

Hematological MalignancyHuman AmlMedicineHypoxia (Medicine)ImmunologyHematologyCancer Cell BiologyPathologyMyeloid NeoplasiaPoor Prognosis FactorHypoxia Inducible FactorCancer BiologyRadiation OncologyCancer ResearchTumor BiologyOxidative StressHealth Sciences